Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis

Mathieu Blanc, Wei Yuan Hsieh, Kevin A. Robertson, Steven Watterson, Guanghou Shui, Paul Lacaze, Mizanur Khondoker, Paul Dickinson, Garwin Sing, Sara Rodríguez-Martín, Peter Phelan, Thorsten Forster, Birgit Strobl, Matthias Müller, Rudolph Riemersma, Timothy Osborne, Markus R. Wenk, Ana Angulo, Peter Ghazal

Research output: Contribution to journalArticle

Abstract

Little is known about the protective role of inflammatory processes in modulating lipid metabolism in infection. Here we report an intimate link between the innate immune response to infection and regulation of the sterol metabolic network characterized by down-regulation of sterol biosynthesis by an interferon regulatory loop mechanism. In time-series experiments profiling genome-wide lipid-associated gene expression of macrophages, we show a selective and coordinated negative regulation of the complete sterol pathway upon viral infection or cytokine treatment with IFNγ or β but not TNF, IL1β, or IL6. Quantitative analysis at the protein level of selected sterol metabolic enzymes upon infection shows a similar level of suppression. Experimental testing of sterol metabolite levels using lipidomic-based measurements shows a reduction in metabolic output. On the basis of pharmacologic and RNAi inhibition of the sterol pathway we show augmented protection against viral infection, and in combination with metabolite rescue experiments, we identify the requirement of the mevalonate-isoprenoid branch of the sterol metabolic network in the protective response upon statin or IFNβ treatment. Conditioned media experiments from infected cells support an involvement of secreted type 1 interferon(s) to be sufficient for reducing the sterol pathway upon infection. Moreover, we show that infection of primary macrophages containing a genetic knockout of the major type I interferon, IFNβ, leads to only a partial suppression of the sterol pathway, while genetic knockout of the receptor for all type I interferon family members, ifnar1, or associated signaling component, tyk2, completely abolishes the reduction of the sterol biosynthetic activity upon infection. Levels of the proteolytically cleaved nuclear forms of SREBP2, a key transcriptional regulator of sterol biosynthesis, are reduced upon infection and IFNβ treatment at both the protein and de novo transcription level. The reduction in srebf2 gene transcription upon infection and IFN treatment is also found to be strictly dependent on ifnar1. Altogether these results show that type 1 IFN signaling is both necessary and sufficient for reducing the sterol metabolic network activity upon infection, thereby linking the regulation of the sterol pathway with interferon anti-viral defense responses. These findings bring a new link between sterol metabolism and interferon antiviral response and support the idea of using host metabolic modifiers of innate immunity as a potential antiviral strategy.

Original languageEnglish (US)
Article numbere1000598
JournalPLoS Biology
Volume9
Issue number3
DOIs
StatePublished - Mar 1 2011
Externally publishedYes

Fingerprint

Biosynthesis
Sterols
Virus Diseases
interferons
Interferons
sterols
Down-Regulation
biosynthesis
infection
Infection
Interferon Type I
Metabolic Networks and Pathways
Macrophages
Transcription
Metabolites
Innate Immunity
Antiviral Agents
macrophages
transcription (genetics)
Genes

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Blanc, M., Hsieh, W. Y., Robertson, K. A., Watterson, S., Shui, G., Lacaze, P., ... Ghazal, P. (2011). Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biology, 9(3), [e1000598]. https://doi.org/10.1371/journal.pbio.1000598

Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. / Blanc, Mathieu; Hsieh, Wei Yuan; Robertson, Kevin A.; Watterson, Steven; Shui, Guanghou; Lacaze, Paul; Khondoker, Mizanur; Dickinson, Paul; Sing, Garwin; Rodríguez-Martín, Sara; Phelan, Peter; Forster, Thorsten; Strobl, Birgit; Müller, Matthias; Riemersma, Rudolph; Osborne, Timothy; Wenk, Markus R.; Angulo, Ana; Ghazal, Peter.

In: PLoS Biology, Vol. 9, No. 3, e1000598, 01.03.2011.

Research output: Contribution to journalArticle

Blanc, M, Hsieh, WY, Robertson, KA, Watterson, S, Shui, G, Lacaze, P, Khondoker, M, Dickinson, P, Sing, G, Rodríguez-Martín, S, Phelan, P, Forster, T, Strobl, B, Müller, M, Riemersma, R, Osborne, T, Wenk, MR, Angulo, A & Ghazal, P 2011, 'Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis', PLoS Biology, vol. 9, no. 3, e1000598. https://doi.org/10.1371/journal.pbio.1000598
Blanc, Mathieu ; Hsieh, Wei Yuan ; Robertson, Kevin A. ; Watterson, Steven ; Shui, Guanghou ; Lacaze, Paul ; Khondoker, Mizanur ; Dickinson, Paul ; Sing, Garwin ; Rodríguez-Martín, Sara ; Phelan, Peter ; Forster, Thorsten ; Strobl, Birgit ; Müller, Matthias ; Riemersma, Rudolph ; Osborne, Timothy ; Wenk, Markus R. ; Angulo, Ana ; Ghazal, Peter. / Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. In: PLoS Biology. 2011 ; Vol. 9, No. 3.
@article{9bac39a6bdc74ebfb9d3e006d583cc75,
title = "Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis",
abstract = "Little is known about the protective role of inflammatory processes in modulating lipid metabolism in infection. Here we report an intimate link between the innate immune response to infection and regulation of the sterol metabolic network characterized by down-regulation of sterol biosynthesis by an interferon regulatory loop mechanism. In time-series experiments profiling genome-wide lipid-associated gene expression of macrophages, we show a selective and coordinated negative regulation of the complete sterol pathway upon viral infection or cytokine treatment with IFNγ or β but not TNF, IL1β, or IL6. Quantitative analysis at the protein level of selected sterol metabolic enzymes upon infection shows a similar level of suppression. Experimental testing of sterol metabolite levels using lipidomic-based measurements shows a reduction in metabolic output. On the basis of pharmacologic and RNAi inhibition of the sterol pathway we show augmented protection against viral infection, and in combination with metabolite rescue experiments, we identify the requirement of the mevalonate-isoprenoid branch of the sterol metabolic network in the protective response upon statin or IFNβ treatment. Conditioned media experiments from infected cells support an involvement of secreted type 1 interferon(s) to be sufficient for reducing the sterol pathway upon infection. Moreover, we show that infection of primary macrophages containing a genetic knockout of the major type I interferon, IFNβ, leads to only a partial suppression of the sterol pathway, while genetic knockout of the receptor for all type I interferon family members, ifnar1, or associated signaling component, tyk2, completely abolishes the reduction of the sterol biosynthetic activity upon infection. Levels of the proteolytically cleaved nuclear forms of SREBP2, a key transcriptional regulator of sterol biosynthesis, are reduced upon infection and IFNβ treatment at both the protein and de novo transcription level. The reduction in srebf2 gene transcription upon infection and IFN treatment is also found to be strictly dependent on ifnar1. Altogether these results show that type 1 IFN signaling is both necessary and sufficient for reducing the sterol metabolic network activity upon infection, thereby linking the regulation of the sterol pathway with interferon anti-viral defense responses. These findings bring a new link between sterol metabolism and interferon antiviral response and support the idea of using host metabolic modifiers of innate immunity as a potential antiviral strategy.",
author = "Mathieu Blanc and Hsieh, {Wei Yuan} and Robertson, {Kevin A.} and Steven Watterson and Guanghou Shui and Paul Lacaze and Mizanur Khondoker and Paul Dickinson and Garwin Sing and Sara Rodr{\'i}guez-Mart{\'i}n and Peter Phelan and Thorsten Forster and Birgit Strobl and Matthias M{\"u}ller and Rudolph Riemersma and Timothy Osborne and Wenk, {Markus R.} and Ana Angulo and Peter Ghazal",
year = "2011",
month = "3",
day = "1",
doi = "10.1371/journal.pbio.1000598",
language = "English (US)",
volume = "9",
journal = "PLoS Biology",
issn = "1544-9173",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis

AU - Blanc, Mathieu

AU - Hsieh, Wei Yuan

AU - Robertson, Kevin A.

AU - Watterson, Steven

AU - Shui, Guanghou

AU - Lacaze, Paul

AU - Khondoker, Mizanur

AU - Dickinson, Paul

AU - Sing, Garwin

AU - Rodríguez-Martín, Sara

AU - Phelan, Peter

AU - Forster, Thorsten

AU - Strobl, Birgit

AU - Müller, Matthias

AU - Riemersma, Rudolph

AU - Osborne, Timothy

AU - Wenk, Markus R.

AU - Angulo, Ana

AU - Ghazal, Peter

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Little is known about the protective role of inflammatory processes in modulating lipid metabolism in infection. Here we report an intimate link between the innate immune response to infection and regulation of the sterol metabolic network characterized by down-regulation of sterol biosynthesis by an interferon regulatory loop mechanism. In time-series experiments profiling genome-wide lipid-associated gene expression of macrophages, we show a selective and coordinated negative regulation of the complete sterol pathway upon viral infection or cytokine treatment with IFNγ or β but not TNF, IL1β, or IL6. Quantitative analysis at the protein level of selected sterol metabolic enzymes upon infection shows a similar level of suppression. Experimental testing of sterol metabolite levels using lipidomic-based measurements shows a reduction in metabolic output. On the basis of pharmacologic and RNAi inhibition of the sterol pathway we show augmented protection against viral infection, and in combination with metabolite rescue experiments, we identify the requirement of the mevalonate-isoprenoid branch of the sterol metabolic network in the protective response upon statin or IFNβ treatment. Conditioned media experiments from infected cells support an involvement of secreted type 1 interferon(s) to be sufficient for reducing the sterol pathway upon infection. Moreover, we show that infection of primary macrophages containing a genetic knockout of the major type I interferon, IFNβ, leads to only a partial suppression of the sterol pathway, while genetic knockout of the receptor for all type I interferon family members, ifnar1, or associated signaling component, tyk2, completely abolishes the reduction of the sterol biosynthetic activity upon infection. Levels of the proteolytically cleaved nuclear forms of SREBP2, a key transcriptional regulator of sterol biosynthesis, are reduced upon infection and IFNβ treatment at both the protein and de novo transcription level. The reduction in srebf2 gene transcription upon infection and IFN treatment is also found to be strictly dependent on ifnar1. Altogether these results show that type 1 IFN signaling is both necessary and sufficient for reducing the sterol metabolic network activity upon infection, thereby linking the regulation of the sterol pathway with interferon anti-viral defense responses. These findings bring a new link between sterol metabolism and interferon antiviral response and support the idea of using host metabolic modifiers of innate immunity as a potential antiviral strategy.

AB - Little is known about the protective role of inflammatory processes in modulating lipid metabolism in infection. Here we report an intimate link between the innate immune response to infection and regulation of the sterol metabolic network characterized by down-regulation of sterol biosynthesis by an interferon regulatory loop mechanism. In time-series experiments profiling genome-wide lipid-associated gene expression of macrophages, we show a selective and coordinated negative regulation of the complete sterol pathway upon viral infection or cytokine treatment with IFNγ or β but not TNF, IL1β, or IL6. Quantitative analysis at the protein level of selected sterol metabolic enzymes upon infection shows a similar level of suppression. Experimental testing of sterol metabolite levels using lipidomic-based measurements shows a reduction in metabolic output. On the basis of pharmacologic and RNAi inhibition of the sterol pathway we show augmented protection against viral infection, and in combination with metabolite rescue experiments, we identify the requirement of the mevalonate-isoprenoid branch of the sterol metabolic network in the protective response upon statin or IFNβ treatment. Conditioned media experiments from infected cells support an involvement of secreted type 1 interferon(s) to be sufficient for reducing the sterol pathway upon infection. Moreover, we show that infection of primary macrophages containing a genetic knockout of the major type I interferon, IFNβ, leads to only a partial suppression of the sterol pathway, while genetic knockout of the receptor for all type I interferon family members, ifnar1, or associated signaling component, tyk2, completely abolishes the reduction of the sterol biosynthetic activity upon infection. Levels of the proteolytically cleaved nuclear forms of SREBP2, a key transcriptional regulator of sterol biosynthesis, are reduced upon infection and IFNβ treatment at both the protein and de novo transcription level. The reduction in srebf2 gene transcription upon infection and IFN treatment is also found to be strictly dependent on ifnar1. Altogether these results show that type 1 IFN signaling is both necessary and sufficient for reducing the sterol metabolic network activity upon infection, thereby linking the regulation of the sterol pathway with interferon anti-viral defense responses. These findings bring a new link between sterol metabolism and interferon antiviral response and support the idea of using host metabolic modifiers of innate immunity as a potential antiviral strategy.

UR - http://www.scopus.com/inward/record.url?scp=79953699055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953699055&partnerID=8YFLogxK

U2 - 10.1371/journal.pbio.1000598

DO - 10.1371/journal.pbio.1000598

M3 - Article

C2 - 21408089

AN - SCOPUS:79953699055

VL - 9

JO - PLoS Biology

JF - PLoS Biology

SN - 1544-9173

IS - 3

M1 - e1000598

ER -